Abiopharma

Kiener Peter A 🟢 acquired 24.4K shares (1 derivative) of Cue Biopharma, Inc. (CUE) at $0.34 Transaction Date: Jan 02, 2026 | Filing ID: 004359

Broadfoot Jill Marie 🟢 acquired 24.4K shares (1 derivative) of Cue Biopharma, Inc. (CUE) at $0.34 Transaction Date: Jan 02, 2026 | Filing ID: 004358

Garzone Pamela 🟢 acquired 24.4K shares (1 derivative) of Cue Biopharma, Inc. (CUE) at $0.34 Transaction Date: Jan 02, 2026 | Filing ID: 004356

Morich Frank 🟢 acquired 24.4K shares (1 derivative) of Cue Biopharma, Inc. (CUE) at $0.34 Transaction Date: Jan 02, 2026 | Filing ID: 004357

Verheyen Patrick 🟢 acquired 24.4K shares (1 derivative) of Cue Biopharma, Inc. (CUE) at $0.34 Transaction Date: Jan 02, 2026 | Filing ID: 004355

📋 Grewal Harpreet (Director) plans to sell 186 shares of Penumbra Inc (at $312.64 each, total $58K) Filed: Jan 06, 2026 | ID: 000147

New Form DEF 14A - Theriva Biologics, Inc. Filed: 2026-01-05 AccNo: 0001104659-26-000633 Size: 435 KB

AngioDynamics Inc (ANGO) Files Form 10-Q

Transactions of Managers and Closely Associated Persons

Transactions of Managers and Closely Associated Persons

Viðskipti stjórnenda og tengdra aðila

Shan David 🔴 sold 44 shares of BECTON DICKINSON & CO (BDX) Transaction Date: Jan 03, 2026 | Filing ID: 000002

Latest About How to Use X (Twitter)

How Does the Samsung Galaxy S20 Ultra Hold Up in 2026?

Death in Paradise Season 15: Complete Guide (Release Date, Cast, Plot & Updates)